Cosela

trilacicilib

Approval

ApplicationNDA 214200
Approval dateFeb 12, 2021
Approval year2021
SponsorPharmacosmos

FDA-approved use

To mitigate chemotherapy-induced myelosuppression in small cell lung cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Cosela: